Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H13NO3 |
| Molecular Weight | 255.2686 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)[C@@H]1CCN2C1=CC=C2C(=O)C3=CC=CC=C3
InChI
InChIKey=OZWKMVRBQXNZKK-LLVKDONJSA-N
InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)/t11-/m1/s1
(R)- enantiomer does not exhibit COX inhibition – it was > 100-fold less active than (S)- enantiomer on both COX subtypes. (R)- enantiomer is about 60 times less potent than the (-)-S isomer in the carrageenan edema test and ca. 230 times less active than the (-)-S isomer in the mouse phenylquinone writhing assay. R-ketorolac is an inhibitor of fatty acid amide hydrolase, but not at physiological concentrations.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
66635-93-6
Created by
admin on Sat Dec 16 11:18:31 UTC 2023 , Edited by admin on Sat Dec 16 11:18:31 UTC 2023
|
PRIMARY | |||
|
76227
Created by
admin on Sat Dec 16 11:18:31 UTC 2023 , Edited by admin on Sat Dec 16 11:18:31 UTC 2023
|
PRIMARY | |||
|
10A5O25ILE
Created by
admin on Sat Dec 16 11:18:31 UTC 2023 , Edited by admin on Sat Dec 16 11:18:31 UTC 2023
|
PRIMARY | |||
|
181818
Created by
admin on Sat Dec 16 11:18:31 UTC 2023 , Edited by admin on Sat Dec 16 11:18:31 UTC 2023
|
PRIMARY |
SUBSTANCE RECORD
